The slip
PARKINSON RECEIPTno. 5188
21 Oct 2026, 09:59 UTCdopamine neurons, braak
predictionACER3 in dopamine neurons tracks Braak Lewy-body stage
registered7d04650107b6eabd
discovery+0.05 p=0.891 n=9
replication+0.78 p=0.013 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.05, p 0.891)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT4a2e4146f96cde73be86fe9f…
follows ce9b61bb31ff…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5188: ACER3 in dopamine neurons, braak
- power
- full sample +0.18 (p 0.476, n 18), 95% CI -0.31 to +0.60. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.20 (p 0.424, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.27 (p 0.273, n 18). could be the mix.
- skeptic
- leave-one-out range +0.08 to +0.29, sign flips 0; without severely affected donors +0.18 (p 0.476, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ACER3 in dopamine neurons.
case closed: nothing better to follow up.